Although research has bipartisan support in the US Congress, and trust in science is above 75% across the country, the Trump administration seems as determined as ever to mortally wound the nation’s s...

The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research ranging in scale from molecular to societal to deliver health breakthroughs in years, not decades.

The Senior Director of Research Programs is responsible for the project management team and for overseeing project monitoring, reporting, and delivery in alignment with research strategy goals and tactics. The role provides strategic guidance to senior ...

A new pill could soon extend dogs’ lives. How will that change our relationship with our pets?

Inflammaging, CRP, and the longevity drugs coming to reduce them

The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research ranging in scale from molecular to societal to deliver health breakthroughs in years, not decades.

The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative hea...

Establishing Reliable Biomarkers of Aging for Longevity Interventions.

The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative hea...

An economic analysis suggests that targeting aging offers potentially larger economic gains than eradicating individual diseases. Slowing aging to increase life expectancy by 1 year is worth US$38 tri...

Three individuals, along with the group accused of supplying the peptides, were fined between $5,000 and $10,000 for their involvement in an incident at the Revolution Against Aging and Death Festival...

ARPA-H will “build the train tracks” for first large clinical studies of aging interventions

What two decades of trials can teach us about translating rapamycin to human aging.

Help Joao Pedro Magalhaes raise money to support University of Birmingham

AFAR is pleased to announce that Board Member Nir Barzilai, MD, has been elected to the Association of American Physicians (AAP), one of the most

The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative hea...

Longevity Fund-backed Loyal is working toward FDA approval of a drug that could help dogs live longer, healthier lives.

Generated by create next app

IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human clinical trials BOSTON, January 28, 2026 – Life Biosciences, Inc., (“Life Bio”) a...

This is the channel for the Aging Research and Drug Discovery meeting (www.agingpharma.org). We reserve the right to remove derogatory, personal and/or non-scientific comments.

BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies Growing preclinical and cli...

What Bloomberg got very wrong about self-driving cars

The FDA recently accepted the Target Animal Safety (TAS) submission for LOY-002, our drug in development for senior dog lifespan extension. Our Director of Veterinmary Medicine, Brennen McKenzie, expl...

GSIG is a collaborative framework to enhance opportunities to explore the intersection between aging biology and the biology of diseases.

It has the world's largest reserves, produces comparatively little, and has a type of oil that the US needs.